She will inaugurate the vaccination virtually, said Abdul Mannan, Secretary of Health Service Division of the Health Ministry on Saturday.
A nurse from the hospital will receive the jab.
Meanwhile, a study of Dhaka University’s Institute of Health Economics found that only 32 percent of Bangladeshis want to take the COVID-19 vaccine, partially due to doubts over the vaccine’s effectiveness and concerns over side-effects.
Also Read: Bangladesh receives 1st consignment of imported Covid vaccine doses
Overall 84 percent people showed interest to take the vaccine at some stage – after a few weeks, months and years - but did not want to take the vaccine right now as they have doubt about efficacy, side-effect and some even believe the vaccines do not work, the study found.
Some 3,560 randomly selected people above 18 years were respondents of the study beginning January 10. The respondents were from 16 upazilas of eight districts in eight divisions and from Dhaka city area.
Also Read: PM to inaugurate Covid-19 vaccination on Jan 27
The vaccination is set to begin when Bangladesh’s Covid-19 fatalities rose to 8,055 with 14 more coronavirus-related deaths in 24 hours Tuesday morning.
“The mortality rate is now 1.51 percent,” the Directorate General of Health Services (DGHS) said in a handout.
Meanwhile, 515 new cases identified pushing up the national tally to 532,916.
Bangladesh reported its first cases on March 8 and the first death on March 18.
The caseload hit 500,000-mark on December 20 while the death toll exceeded 7,000 on December 12.
Also Read: DGDA OKs use of Oxford-AstraZeneca COVID-19 vaccine
On Tuesday, the Directorate General of Drug Administration (DGDA) cleared Oxford-AstraZeneca COVID-19 vaccine for use after testing samples of the 5 million doses brought from India on Monday.
“We’ve thoroughly tested samples from the consignment,” DGDA Director General Maj Gen Mahbubur Rahman told a press briefing in Dhaka on Tuesday.
Also Read: 32pc of Bangladeshis want to take covid vaccine now: study
Bangladesh approved the emergency use of this vaccine on Jan 7. It inked a deal with the Serum Institute of India Pvt Ltd last month for procuring 30 million doses of the vaccine between January and June (five million doses each month).
The country received 2 million doses of vaccine as ‘gift’ from India last week.